140 related articles for article (PubMed ID: 10451877)
1. Effective and economical option for pain palliation in prostate cancer with skeletal metastases: 32P therapy revisited.
Shah Syed GM; Maken RN; Muzzaffar N; Shah MA; Rana F
Nucl Med Commun; 1999 Aug; 20(8):697-702. PubMed ID: 10451877
[TBL] [Abstract][Full Text] [Related]
2. Relative efficacy of 32P and 89Sr in palliation in skeletal metastases.
Nair N
J Nucl Med; 1999 Feb; 40(2):256-61. PubMed ID: 10025832
[TBL] [Abstract][Full Text] [Related]
3. Strontium 89 therapy for the palliation of pain due to osseous metastases.
Robinson RG; Preston DF; Schiefelbein M; Baxter KG
JAMA; 1995 Aug; 274(5):420-4. PubMed ID: 7542352
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of 177Lu-EDTMP in bone metastatic pain palliation in breast cancer and hormone refractory prostate cancer: a phase II study.
Yuan J; Liu C; Liu X; Wang Y; Kuai D; Zhang G; Zaknun JJ
Clin Nucl Med; 2013 Feb; 38(2):88-92. PubMed ID: 23334120
[TBL] [Abstract][Full Text] [Related]
5. Does renal damage occur after the administration of 32P for palliation of pain from skeletal metastases?
Nair N; Mahadeo DS; Patel R
Nucl Med Commun; 1998 Jul; 19(7):689-93. PubMed ID: 9853350
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of radioactive phosphorus in the palliation of metastatic bone lesions from carcinoma of the breast and prostate.
Cheung A; Driedger AA
Radiology; 1980 Jan; 134(1):209-12. PubMed ID: 6153129
[TBL] [Abstract][Full Text] [Related]
7. (153)Sm-EDTMP for pain relief of bone metastases from prostate and breast cancer and other malignancies.
Correa-González L; Arteaga de Murphy C; Pichardo-Romero P; Pedraza-López M; Moreno-García C; Correa-Hernández L
Arch Med Res; 2014 May; 45(4):301-8. PubMed ID: 24681187
[TBL] [Abstract][Full Text] [Related]
8. Radionuclide therapy of cancer patients with bone metastases.
Yaneva MP; Semerdjieva M; Radev LR; Ivanova EK; Geiman M; Vlaikova MI; Mihova LS
Folia Med (Plovdiv); 2005; 47(3-4):63-9. PubMed ID: 16761397
[TBL] [Abstract][Full Text] [Related]
9. Comparison of 32P therapy and sequential hemibody irradiation (HBI) for bony metastases as methods of whole body irradiation.
Aziz H; Choi K; Sohn C; Yaes R; Rotman M
Am J Clin Oncol; 1986 Jun; 9(3):264-8. PubMed ID: 2425617
[TBL] [Abstract][Full Text] [Related]
10. Bone pain palliation with 85Sr therapy.
Giammarile F; Mognetti T; Blondet C; Desuzinges C; Chauvot P
J Nucl Med; 1999 Apr; 40(4):585-90. PubMed ID: 10210217
[TBL] [Abstract][Full Text] [Related]
11. Samarium-153 ethylenediamine tetramethylene phosphonate therapy for bone pain palliation in skeletal metastases.
Tripathi M; Singhal T; Chandrasekhar N; Kumar P; Bal C; Jhulka PK; Bandopadhyaya G; Malhotra A
Indian J Cancer; 2006; 43(2):86-92. PubMed ID: 16790946
[TBL] [Abstract][Full Text] [Related]
12. [Radioactive substances (32P and 89Sr) in the treatment of pain in bone metastases].
Flamm J; Burkert S
Z Urol Nephrol; 1981 Nov; 74(11):801-6. PubMed ID: 6172913
[TBL] [Abstract][Full Text] [Related]
13. Considerations in the selection of radiopharmaceuticals for palliation of bone pain from metastatic osseous lesions.
Bouchet LG; Bolch WE; Goddu SM; Howell RW; Rao DV
J Nucl Med; 2000 Apr; 41(4):682-7. PubMed ID: 10768569
[TBL] [Abstract][Full Text] [Related]
14. Strontium-89 chloride (Metastron) for palliative treatment of bony metastases. The University of Minnesota experience.
Lee CK; Aeppli DM; Unger J; Boudreau RJ; Levitt SH
Am J Clin Oncol; 1996 Apr; 19(2):102-7. PubMed ID: 8610630
[TBL] [Abstract][Full Text] [Related]
15. Bone pain palliation with strontium-89 in breast cancer patients with bone metastases and refractory bone pain.
Berna L; Carrio I; Alonso C; Ferré J; Estorch M; Torres G
Eur J Nucl Med; 1995 Oct; 22(10):1101-4. PubMed ID: 8542891
[TBL] [Abstract][Full Text] [Related]
16. [186Re]HEDP in the palliation of painful bone metastases from cancers other than prostate and breast.
Minutoli F; Herberg A; Spadaro P; Restifo Pecorella G; Baldari S; Aricò D; Altavilla G; Baldari S
Q J Nucl Med Mol Imaging; 2006 Dec; 50(4):355-62. PubMed ID: 17043634
[TBL] [Abstract][Full Text] [Related]
17. Significant reduction of the mass of bone metastasis 1 year after rhenium-186 HEDP pain palliation therapy.
Liepe K; Kropp J; Hliscs R; Franke WG
Clin Nucl Med; 2000 Nov; 25(11):901-4. PubMed ID: 11079588
[TBL] [Abstract][Full Text] [Related]
18. Marrow toxicity of 33P-versus 32P-orthophosphate: implications for therapy of bone pain and bone metastases.
Goddu SM; Bishayee A; Bouchet LG; Bolch WE; Rao DV; Howell RW
J Nucl Med; 2000 May; 41(5):941-51. PubMed ID: 10809212
[TBL] [Abstract][Full Text] [Related]
19. 32P-pyrophosphate in the treatment of persistent metastatic bone pain.
Werner B; Isacson C; Lundell G; Lönnbeck C; Söderborg B
Acta Radiol Oncol; 1980; 19(5):327-9. PubMed ID: 6163323
[TBL] [Abstract][Full Text] [Related]
20. Use of strontium-89 in endocrine-refractory prostate cancer metastatic to bone. Provincial Genitourinary Cancer Disease Site Group.
Brundage MD; Crook JM; Lukka H
Cancer Prev Control; 1998 Apr; 2(2):79-87. PubMed ID: 9765768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
